Potential diagnostic use of p16INK4A, a new marker that correlates with dysplasia in oral squamoproliferative lesions

American Journal of Surgical Pathology

Volumn 29, Issue 6, 2005, Pages 792-796

  Gologan, Olguta ^a   Barnes, E Leon ^a   Hunt, Jennifer L ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Dysplasia; Head and neck cancer; p16; Squamous cell carcinoma

Indexed keywords

CELL MARKER; PROTEIN P16INK4A;

ARTICLE; CANCER GRADING; CELL CYCLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DYSPLASIA; GENE EXPRESSION REGULATION; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATOSIS; MAJOR CLINICAL STUDY; MOUTH TUMOR; PROTEIN ANALYSIS; SQUAMOUS CELL CARCINOMA; STAINING; TUMOR SUPPRESSOR GENE; ULCER;

CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL;

EID: 19544374893     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000163361.40357.b8     Document Type: Article

References (20)

1. Ai L, Stephenson KK, Ling W, et al. The p 16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Mod Pathol. 2003; 16:944-950.
2. Ambrosch P, Schlott T, Hilmes D, et al. p 16 alterations and retinoblastoma protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract. Virchows Arch. 2001;438:343-349.
3. Bockmuhl U, Petersen I. DNA ploidy and chromosomal alterations in head and neck squamous cell carcinoma. Virchows Arch. 2002;441:541-550.
4. Fregonesi PA. P16INK4A immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem. 2003;51:1291-1297.
5. Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2003;260:502-508.
6. Ibrahim SO, Lillehaug JR, Vasstrand EN. Mutations of the cell cycle regulatory genes p16INK4A and p21WAF1 and the metastasis-inducing gene S100A4 are infrequent and unrelated to p53 tumour suppressor gene status and data on survival in oropharyngeal squamous cell carcinomas. Anticancer Res. 2003;23:4593-4600.
7. Kresty LA, Mallery SR. Alteration of p16INK4A and p14ARF in patients with severe oral dysplasia. Cancer Res. 2002;62:5295-5300.
8. McGregor F, Muntoni A, Fleming J, et al. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. Cancer Res. 2002;62:4757-4766.
9. Murphy N, Ring M, Killalea AG, et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol. 2003;56:56-63.
10. Namazie A, Alavi S, Olopade OI, et al. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope. 2002;112:472-481.
11. Oliver RJ, MacDonald DG, Felix DH. Aspects of cell proliferation in oral epithelial dysplastic lesions. J Oral Pathol Med. 2000;29:49-55.
12. Sano T, Masuda N, Oyama T, et al. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int. 2002;52:375-383.
13. Saunders JR Jr. The genetic basis of head and neck carcinoma. Am J Surg. 1997;174:459-461.
14. Sudbo J, Lippman SM, Lee JJ, et al. The influence of resection and aneuploidy on mortality in oral leukoplakia [see comment]. N Engl J Med. 2004;350:1405-1413.
15. van de Putte G, Holm R, Lie AK, et al. Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis [erratum appears in Gynecol Oncol. 2004;92:730]. Gynecol Oncol. 2003; 89:140-147.
16. Wenig BM. Squamous cell carcinoma of the upper aerodigestive tract: precursor and problematic variants. Mod Pathol. 2002;15:229-254.
17. Wong TS, Man MW, Lam AK, et al. The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR. Eur J Cancer. 2003; 39:1881-1887.
18. Worsham MJ, Pals G, Scheuten JP, et al. Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129:702-708.
19. Xing EP, Nie Y, Song Y, et al. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4A genes in human esophageal squamous cell carcinoma. Clin Cancer Res. 1999;5:2704-2713.
20. Zhang L, Rosin MP. Loss of heterozygosity: a potential tool in management of oral premalignant lesions? J Oral Pathol Med. 2001;30:513-520.